Security key
09071M304
BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX)
CUSIP: 09071M304
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.10 per share
- Total 13F shares
- 47,750
- Total 13F value
- $135,626
- Share change
- +18,655
- Put/Call ratio
- 103%
- SEC-reported price per share
- $2.77
- Number of holders
- 13
- Value change
- +$53,947
- Number of buys
- 5
- Number of sells
- 4
- Shares outstanding
- 2,402,091,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
13
Top holders
10
BLRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
BioLineRx Ltd. SEC filings
BioLineRx Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09071M304
Recent filing periods:
Ownership snapshot
Top reported holders of BLRX - BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HIGHBRIDGE CAPITAL MANAGE...
Disclosed value leader
HIGHBRIDGE CAPITAL MANAGE...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 7.2%
13D/G row: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Quick read
HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
HIGHBRIDGE CAPITAL MANAGEMENT LLC
7.2%
INTRACOASTAL CAPITAL, LLC
5%
CITADEL ADVISORS LLC
0%
UBS Group AG
0%
MORGAN STANLEY
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
7.2%
|
$818,056,338
172,950,600 shares
|
$0 | 30 Jun 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$11,245,973
102,236,115 shares
|
$0 | 06 Jan 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
0%
|
$37,876
10,020 shares
|
— | 30 Sep 2025 |
| UBS Group AG |
13F
Company
|
0%
|
$24,143
6,387 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$22,503
5,953 shares
|
— | 30 Sep 2025 |
| RHUMBLINE ADVISERS |
13F
Company
|
0%
|
$11,602
3,070 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
47,750
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
13
Q4 2025 holders
13
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend